logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Paul H Johnson

This inventor holds 8 USPTO granted patents. Top assignees: Sri International, Nippon Mining Co., Ltd.. Active years: 1990-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul H Johnson. Retrieved from https://idiyas.com/inventor/paul-h-johnson-5dlcnoxl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 70(Granted Patents)


Company Filing History:

goldMedal7 out of 1,361 
 
Sri International
 patents
silverMedal1 out of 141 
 
Nippon Mining Co., Ltd.
 patents

Years Active: 1990-1994

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5317011 - Cloning and expression of a variant gene of platelet factor 4 and (1994-05-31),
2. 5187075 - Cloning and expression of a variant gene of platelet factor 4 and (1993-02-16),
3. 5179196 - Purification of proteins employing CTAP-III fusions (1993-01-12),
4. 5175251 - Antimetastatic peptides with laminin activity (1992-12-29),
5. 5164304 - Method and vectors for stabilizing hirudin and human laminin B.sub.1 (1992-11-17),
6. 5118790 - Analogs of hirudin (1992-06-02),
7. 5026639 - Method to improve mRNA translation and use thereof for production of (1991-06-25),
8. 4897348 - Recombinant materials and methods for producing human connective (1990-01-30),

Title: Paul H Johnson: Innovator in Platelet Factor Research

Introduction

Paul H Johnson is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of platelet factor research. With a total of 8 patents to his name, Johnson's work has had a profound impact on medical science.

Latest Patents

Among his latest patents, Johnson has developed methods for the cloning and expression of a variant gene of platelet factor 4. His inventions provide for the purification from native sources or the cloning and expression of a variant form of platelet factor 4. Additionally, he has created recombinant DNA vectors and methods for the expression and recovery of the platelet factor 4 variant. His work also includes compositions and methods for modulating immune responses in mammals, which comprise immunomodulating effective amounts of the platelet factor 4 variant.

Career Highlights

Throughout his career, Johnson has worked with esteemed organizations such as SRI International and Nippon Mining Co., Ltd. His innovative research has positioned him as a leader in his field, contributing to advancements in biotechnology and immunology.

Collaborations

Johnson has collaborated with notable colleagues, including Jerome B Lazar and Nahid S Waleh. These partnerships have further enhanced the scope and impact of his research.

Conclusion

Paul H Johnson's contributions to the field of biotechnology, particularly through his patents related to platelet factor 4, demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapeutic methods and compositions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…